OBOYLE KEVIN C 4

What Happened Kevin C. O'Boyle, a director of Outset Medical, was granted 10,667 restricted stock units (RSUs) on June 4, 2026. The award was reported on a Form 4 filed June 5, 2026. The RSUs were granted at a $0.00 price (standard for equity awards) and represent future delivery of common stock subject to vesting conditions.

Key Details

• Transaction date: 2026-06-04; Transaction code: A (award/grant)
• Shares granted: 10,667 RSUs; price reported: $0.00 (no cash purchase)
• Filing date: 2026-06-05 (filed the next day; within typical Form 4 timing rules)
• Shares owned after transaction: not specified in the provided filing summary
• Footnote: F1 — "100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders."

Context This was an equity compensation award, not an open-market purchase or sale. RSUs generally indicate compensation or retention incentives and do not reflect an immediate cash outlay or sale by the insider. Vesting is time- or event-based (here, one year or next annual meeting), so the shares are not yet owned outright until vesting conditions are met. The Form 4 was filed promptly the following day.